Al-Nimer, M. S. M., Al-Kuraishy, H. M., & Al-Gareeb, A. (2012). Omega-3 fatty acids improve psychomotor performance via mechanism not related to nitric acid production. International Journal of Green Pharmacy, 6(1), 1–4. doi:10.4103/0973-8258.97102
Antypa, N., Van der Does, A. J. W., Smelt, A. H. M., & Rogers, R. D. (2008). Omega-3 fatty acids (fish-oil) and depression-related cognition in healthy volunteers. Journal of Psychopharmacology, 23(7), 831–840. doi:10.1177/0269881108092120
Balentine, D. (2019). RE: Petition for a Health Claim for Eicosapentaenoic Acid and Docosahexaenoic Acid and Reduction of Blood Pressure in the General Population (Docket No. FDA-2014-Q-1146). Retrieved 12 July 2021 from https://www.fda.gov/media/128043/download
Benton, D., Donohoe, R. T., Clayton, D. E., & Long, S. J. (2012). Supplementation with DHA and the psychological functioning of young adults. British Journal of Nutrition, 109(1), 155–161. doi:10.1017/s0007114512000566
Detopoulou, P., & Papamikos, V. (2014). Gastrointestinal bleeding after high intake of omega-3 fatty acids, cortisone and antibiotic therapy: A case study. International Journal of Sport Nutrition and Exercise Metabolism, 24(3), 253–257. doi:10.1123/ijsnem.2013-0204
Dretsch, M. N., Johnston, D., Bradley, R. S., MacRae, H., Deuster, P. A., & Harris, W. S. (2014). Effects of omega-3 fatty acid supplementation on neurocognitive functioning and mood in deployed U.S. Soldiers: A pilot study. Military Medicine, 179(4), 396–403. doi:10.7205/milmed-d-13-00395
Fontani, G., Corradeschi, F., Felici, A., Alfatti, F., Migliorini, S., & Lodi, L. (2005). Cognitive and physiological effects of omega-3 polyunsaturated fatty acid supplementation in healthy subjects. European Journal of Clinical Investigation, 35(11), 691–699. doi:10.1111/j.1365-2362.2005.01570.x
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., . . . Stoll, A. L. (2006). Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry. The Journal of Clinical Psychiatry, 67(12), 1954–1967. doi:10.4088/JCP.v67n1217
Giles, G. E., Mahoney, C. R., Urry, H. L., Brunyé, T. T., Taylor, H. A., & Kanarek, R. B. (2015). Omega-3 fatty acids and stress-induced changes to mood and cognition in healthy individuals. Pharmacology Biochemistry and Behavior, 132, 10–19. doi:10.1016/j.pbb.2015.02.018
Gross, B. W., Gillio, M., Rinehart, C. D., Lynch, C. A., & Rogers, F. B. (2017). Omega-3 fatty acid supplementation and warfarin. Journal of Trauma Nursing, 24(1), 15–18. doi:10.1097/jtn.0000000000000256
Institute of Medicine, & Food and Nutrition Board. (2005). Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: The National Academies Press.
Jackson, P. A., Deary, M. E., Reay, J. L., Scholey, A. B., & Kennedy, D. O. (2011). No effect of 12 weeks' supplementation with 1 g DHA-rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18–35 years. British Journal of Nutrition, 107(8), 1232–1243. doi:10.1017/s000711451100403x
Jackson, P. A., Reay, J. L., Scholey, A. B., & Kennedy, D. O. (2012). Docosahexaenoic acid-rich fish oil modulates the cerebral hemodynamic response to cognitive tasks in healthy young adults. Biological Psychology, 89(1), 183–190. doi:10.1016/j.biopsycho.2011.10.006
Jeansen, S., Witkamp, R. F., Garthoff, J. A., van Helvoort, A., & Calder, P. C. (2018). Fish oil LC-PUFAs do not affect blood coagulation parameters and bleeding manifestations: Analysis of 8 clinical studies with selected patient groups on omega-3-enriched medical nutrition. Clinical Nutrition, 37(3), 948–957. doi:10.1016/j.clnu.2017.03.027
Karr, J. E., Grindstaff, T. R., & Alexander, J. E. (2012). Omega-3 polyunsaturated fatty acids and cognition in a college-aged population. Experimental and Clinical Psychopharmacology, 20(3), 236–242. doi:10.1037/a0026945
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2003). Omega-3 fatty acids and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 23(2), 151–152. doi:10.1161/01.Atv.0000057393.97337.Ae
Leckie, R. L., Lehman, D. E., Gianaros, P. J., Erickson, K. I., Sereika, S. M., Kuan, D. C. H., . . . Muldoon, M. F. (2019). The effects of omega-3 fatty acids on neuropsychological functioning and brain morphology in mid-life adults: A randomized clinical trial. Psychological Medicine, 50(14), 2425–2434. doi:10.1017/s0033291719002617
McClaskey, E. M., & Michalets, E. L. (2007). Subdural hematoma after a fall in an elderly patient taking high-dose omega-3 fatty acids with warfarin and aspirin: Case report and review of the literature. Pharmacotherapy, 27(1), 152–160. doi:10.1592/phco.27.1.152
Oliver, J. M., Jennings, W., Askow, A., Gable, D., Kirk, K. M., Harris, W., . . . Anzalone, A. (2019). The omega-3 index in National Collegiate Athletic Association Division I collegiate football athletes. Journal of Athletic Training, 54(1), 7–11. doi:10.4085/1062-6050-387-18
Stark, K. D., Van Elswyk, M. E., Higgins, M. R., Weatherford, C. A., & Salem, N. (2016). Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Progress in Lipid Research, 63, 132–152. doi:10.1016/j.plipres.2016.05.001
Stonehouse, W., Conlon, C. A., Podd, J., Hill, S. R., Minihane, A. M., Haskell, C., & Kennedy, D. (2013). DHA supplementation improved both memory and reaction time in healthy young adults: A randomized controlled trial. The American Journal of Clinical Nutrition, 97(5), 1134–1143. doi:10.3945/ajcn.112.053371
Thompson, M., Hein, N., Hanson, C., Smith, L., Anderson-Berry, A., Richter, C., . . . Nordgren, T. (2019). Omega-3 fatty acid intake by age, gender, and pregnancy status in the United States: National Health and Nutrition Examination Survey 2003–2014. Nutrients, 11(1), Article 177. doi:10.3390/nu11010177
U.S. Department of Health and Human Services & U.S. Department of Agriculture. (2015). 2015 – 2020 Dietary Guidelines for Americans. (8th ed.). Washington, DC: U.S. Department of Health and Human Services and U.S. Department of Agriculture.
U.S. Food & Drug Administration. (2019). FDA announces new qualified health claims for EPA and DHA omega-3 consumption and the risk of hypertension and coronary heart disease. Retrieved 22 January 2021 from https://www.fda.gov/food/cfsan-constituent-updates/fda-announces-new-qualified-health-claims-epa-and-dha-omega-3-consumption-and-risk-hypertension-and